MedTrace Logo

Management of the Third Stage of Labor

NCT02319707 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2015-09-09

No results posted yet for this study

Summary

To compare the efficacy of three different protocols of third stage management in preventing PPH.

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

Oxytocin

The study group: divided into two groups: • Intramuscular treatment: pregnant women, 34-41 weeks of gestation, which were treated with 10 IU of IM Oxytocin during the third stage of labor. • Combined treatment: pregnant women, 34-41 weeks of gestation, which were treated with 10 IU of IM Oxytocin together with 10 IU of IV Oxytocin in 100 ml NaCl 0.9% during the third stage of labor.

DRUG

Oxytocin in 100 ml NaCl 0.9%

The control group: pregnant women, 34-41 weeks of gestation, which were treated with 10 IU of IV Oxytocin in 100 ml NaCl 0.9% during the third stage of labor. (this is the routine practice in our department).

Sponsors & Collaborators

  • Yariv yogev

    lead OTHER

Principal Investigators

  • Yariv Yogev, professor · Director, Division of obstetrics and delivery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-01-31
Completion
2017-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02319707 on ClinicalTrials.gov